collagen triple helix repeat containing 1 (CTHRC1)

July 23, 2024

CTHRC1 is associated with BRAF(V600E) mutation and correlates with prognosis, immune cell infiltration, and drug resistance in colon cancer, thyroid cancer, and melanoma

Abstract Colon cancer, thyroid cancer, and melanoma are common malignant tumors that seriously threaten human health globally. The B-Raf proto-oncogene,…

October 26, 2021

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers

Abstract Background: The function of collagen triple helix repeat containing 1 (CTHRC1) as an oncogene has been reported in a…

February 8, 2021

CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma

Abstract Kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) are the most common RCC types.…